Skip to content

Atrial Fibrillation Ablation Registry

Atrial Fibrillation Ablation Registry Protocol Number: 3122-2016

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04055961
Acronym
AFib
Enrollment
5000
Registered
2019-08-14
Start date
2019-05-20
Completion date
2025-05-20
Last updated
2023-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

The Atrial Fibrillation Ablation Registry (AFib Ablation Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous catheter ablation procedures to treat atrial fibrillation (AF).

Detailed description

The Atrial Fibrillation Ablation Registry (AFib Ablation Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous catheter ablation procedures to treat atrial fibrillation (AF). Patient-level data will be submitted by participating hospitals on a quarterly basis to the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR™). The primary aims of the AFib Ablation Registry are to optimize the outcomes and management of patients through the implementation of evidence-based guideline recommendations in clinical practice, facilitate efforts to improve the quality and safety for patients undergoing percutaneous catheter ablation procedures, investigate novel quality improvement methods and provide risk-adjusted assessment of patients for comparison with nationwide NCDR data. The secondary purpose of the AFib Ablation Registry is to serve as a rich source of clinical data to support assessments of short- and long-term safety, comparative and cost effectiveness research, and as a scalable data infrastructure for post market studies.

Interventions

DEVICEAtrial Fibrillation Ablation

A procedure used to treat an irregular heart rhythm (arrhythmia)

Sponsors

Hoag Memorial Hospital Presbyterian
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients 2. 18 years and older 3. Undergoing percutaneous catheter ablation procedures to treat atrial fibrillation

Exclusion criteria

1\. none

Design outcomes

Primary

MeasureTime frameDescription
Unsuccessful treatment rate1 yearmeasured by the number of repeated procedure

Secondary

MeasureTime frameDescription
Adverse Events1 yearNumber of participants with adverse events that are related to treatment (i.e. cardiac tamponade, periprocedural stroke, pulmonary vein stenosis, esophageal damage, etc)

Countries

United States

Contacts

Primary ContactColleen Balius
colleen.balius@hoag.org9497641497

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026